BioSpace News Archive

Press Releases

Hemex expands Global Clinical Network Alliance to strengthen end-to-end CRO Capabilities

September 2, 2025
·
3 min read
Press Releases

BioInvent Announces Board of Directors Update

September 2, 2025
·
2 min read
Press Releases

Akeso Announces Completion of Patient Enrollment in Phase III Clinical Trial for Ivonescimab as First-Line Treatment for Biliary Tract Cancer Compared to PD-L1 Therapy

September 2, 2025
·
6 min read
Press Releases

Polpharma Biologics and MS Pharma Sign Licensing Agreements for Proposed Vedolizumab (PB016), Ocrelizumab (PB018) and Guselkumab (PB019) Biosimilars

September 2, 2025
·
5 min read
Press Releases

OBI Pharma Announces Phase 1/2 Study Initiation for OBI-902, a TROP2 Targeted Antibody-Drug Conjugate Therapy (ADC) in Advanced Solid Tumors

September 2, 2025
·
5 min read
Press Releases

Supercharging Antibody Drug Discovery with AI: The Rise of Chai-2 and Patsnap’s Lao Tzu Dataset

September 2, 2025
·
1 min read
Press Releases

US Food and Drug Administration (FDA) Approves Henlius and Organon’s BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively

September 2, 2025
·
19 min read
Press Releases

Zymeworks Announces Decision to Discontinue Clinical Development of ZW171, a Mesothelin-directed T cell Engager

September 2, 2025
·
7 min read
Press Releases

Upstream Bio Reports Positive Top-Line Results from the Phase 2 VIBRANT Trial of Verekitug for the Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

September 2, 2025
·
12 min read
Press Releases

Servier and IDEAYA Biosciences Partner to Bring Darovasertib, a Promising Uveal Melanoma Treatment, to Patients Worldwide

September 2, 2025
·
8 min read